| 000 | 02698 a2200769 4500 | ||
|---|---|---|---|
| 005 | 20250514183637.0 | ||
| 264 | 0 | _c20041007 | |
| 008 | 200410s 0 0 eng d | ||
| 022 | _a1524-4571 | ||
| 024 | 7 |
_a10.1161/01.RES.0000126924.23467.A3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIshibashi, Minako | |
| 245 | 0 | 0 |
_aCritical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. _h[electronic resource] |
| 260 |
_bCirculation research _cMay 2004 |
||
| 300 |
_a1203-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin II _xtoxicity |
| 650 | 0 | 4 | _aAngiotensin II Type 1 Receptor Blockers |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta _xdrug effects |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aChemokine CCL2 _xbiosynthesis |
| 650 | 0 | 4 |
_aChemotaxis, Leukocyte _xphysiology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xetiology |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 | _aInfusion Pumps, Implantable |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 | _aOlmesartan Medoxomil |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRadiation Chimera |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 | _aRats, Inbred WKY |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 1 _xdeficiency |
| 650 | 0 | 4 | _aReceptors, CCR2 |
| 650 | 0 | 4 |
_aReceptors, Chemokine _xdeficiency |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xphysiology |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xgenetics |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aHiasa, Ken-ichi | |
| 700 | 1 | _aZhao, Qingwei | |
| 700 | 1 | _aInoue, Shujiro | |
| 700 | 1 | _aOhtani, Kisho | |
| 700 | 1 | _aKitamoto, Shiro | |
| 700 | 1 | _aTsuchihashi, Miyuki | |
| 700 | 1 | _aSugaya, Takeshi | |
| 700 | 1 | _aCharo, Israel F | |
| 700 | 1 | _aKura, Shinobu | |
| 700 | 1 | _aTsuzuki, Teruhisa | |
| 700 | 1 | _aIshibashi, Tatsuro | |
| 700 | 1 | _aTakeshita, Akira | |
| 700 | 1 | _aEgashira, Kensuke | |
| 773 | 0 |
_tCirculation research _gvol. 94 _gno. 9 _gp. 1203-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.RES.0000126924.23467.A3 _zAvailable from publisher's website |
| 999 |
_c14775877 _d14775877 |
||